Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study

BACKGROUND: There is underutilization of long-acting injectable (LAI) antipsychotics for first-episode schizophrenia (FES) despite having convenient dosing and treatment retention. LAIs are predominantly used for patients with poor compliance, chronic course, and multiple relapses. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Ramandeep, Sidana, Ajeet, Malhotra, Nidhi, Tyagi, Shikha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263095/
https://www.ncbi.nlm.nih.gov/pubmed/37325092
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_389_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263095/
https://www.ncbi.nlm.nih.gov/pubmed/37325092
http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_389_22

Ejemplares similares